We are live on ! Find out more

1,601 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 577 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 151 | Existing positions closed: 71

22% more funds holding in top 10

Funds holding in top 10: 6579 (+14)

18% more repeat investments, than reductions

Existing positions increased: 680 | Existing positions reduced: 577

13% more capital invested

Capital invested by funds: $85.1B → $95.7B (+$10.7B)

4% more funds holding

Funds holding: 1,5421,601 (+59)

1.05% more ownership

Funds ownership: 78.1%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,601
Holders Change
+59
Holders Change %
+3.83%
% of All Funds
39.85%
Holding in Top 10
79
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+21.54%
% of All Funds
1.97%
New
151
Increased
680
Reduced
577
Closed
71
Calls
$1.14B
Puts
$1.7B
Net Calls
-$562M
Net Calls Change
-$95.5M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
151
Saturna Capital
Washington
$59.7M -$2.37M -14,240 -4%
Robeco Institutional Asset Management
152
Robeco Institutional Asset Management
Netherlands
$59.6M -$10.6M -63,568 -15%
CAM
153
ClariVest Asset Management
California
$58.9M -$2.17M -13,065 -4%
AIG
154
American International Group
New York
$57.8M +$650K +3,909 +1%
Zurich Cantonal Bank
155
Zurich Cantonal Bank
Switzerland
$57.8M -$844K -5,081 -1%
First Trust Advisors
156
First Trust Advisors
Illinois
$57.5M -$23M -138,147 -28%
PA
157
Profund Advisors
Maryland
$57.1M -$4.61M -27,752 -7%
M&T Bank
158
M&T Bank
New York
$57M -$2.4M -14,456 -4%
CCMH
159
Cornerstone Capital Management Holdings
New York
$56M -$11.2M -67,455 -17%
AG
160
Aperio Group
California
$54.9M +$4.22M +25,405 +8%
N
161
Natixis
France
$54.5M +$47.1M +283,592 +583%
Federated Hermes
162
Federated Hermes
Pennsylvania
$54.3M -$9.46M -56,933 -15%
Baird Financial Group
163
Baird Financial Group
Wisconsin
$53.1M +$29.2M +175,629 +118%
HighTower Advisors
164
HighTower Advisors
Illinois
$52.6M +$9.45M +56,851 +22%
Comerica Bank
165
Comerica Bank
Texas
$51.9M -$3.93M -23,646 -7%
RCAMU
166
Rothschild & Co Asset Management US
Connecticut
$51.5M -$180K -1,083 -0.3%
CIBC World Market
167
CIBC World Market
Ontario, Canada
$51.2M -$11.9M -71,820 -19%
SGAM
168
Smith Group Asset Management
Texas
$50.8M -$3.74M -22,500 -7%
TRSOTSOK
169
Teachers Retirement System of the State of Kentucky
Kentucky
$50.5M -$4.62M -27,825 -8%
BA
170
Boston Advisors
Massachusetts
$50.4M -$2M -12,012 -4%
DLA
171
Douglas Lane & Associates
New York
$48.7M -$2.32M -13,973 -4%
BC
172
Bartlett & Co
Ohio
$47.7M -$560K -3,371 -1%
KeyBank National Association
173
KeyBank National Association
Ohio
$47.6M +$315K +1,897 +0.7%
Natixis Advisors
174
Natixis Advisors
Massachusetts
$47.3M +$7.32M +44,046 +18%
Nisa Investment Advisors
175
Nisa Investment Advisors
Missouri
$47.2M +$174K +1,050 +0.4%

AMGN Hedge Fund Activity: Q1 2017 in Review

1,601 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2017, worth a combined $95.7B — up 13% from $85.1B a quarter earlier.

Buyers outnumbered sellers: 151 funds opened new AMGN positions and 71 closed out — a net gain of 80 holders — while 680 added to existing stakes and 577 trimmed.

The largest buyer was BlackRock, adding an estimated $7.72B. The largest seller was Capital Research Global Investors, cutting an estimated $1.36B.

  • 1,601 institutional investors held Amgen (AMGN) as of Q1 2017, up from 1,542 in Q4 2016.
  • Funds reported $95.7B of Amgen stock for Q1 2017, up 13% quarter-over-quarter.
  • 151 funds opened new Amgen positions in Q1 2017 and 71 closed out, a net change of +80 holders.
  • The largest Amgen buyer in Q1 2017 was BlackRock, an estimated $7.72B added.
  • The largest Amgen seller in Q1 2017 was Capital Research Global Investors, an estimated $1.36B sold.

Based on aggregated 13F filings for Q1 2017.